Terumo (OTCMKTS:TRUMY – Get Free Report) and SS Innovations International (NASDAQ:SSII – Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, institutional ownership, profitability and earnings.
Profitability
This table compares Terumo and SS Innovations International’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Terumo | 13.83% | 10.44% | 7.34% |
| SS Innovations International | -23.73% | -26.77% | -15.01% |
Earnings and Valuation
This table compares Terumo and SS Innovations International”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Terumo | $7.52 billion | 2.80 | $897.03 million | $0.71 | 20.11 |
| SS Innovations International | $42.49 million | 12.45 | -$12.13 million | ($0.06) | -44.00 |
Terumo has higher revenue and earnings than SS Innovations International. SS Innovations International is trading at a lower price-to-earnings ratio than Terumo, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
Terumo has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500. Comparatively, SS Innovations International has a beta of -1.79, indicating that its share price is 279% less volatile than the S&P 500.
Analyst Recommendations
This is a summary of recent recommendations and price targets for Terumo and SS Innovations International, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Terumo | 0 | 1 | 0 | 1 | 3.00 |
| SS Innovations International | 1 | 0 | 0 | 0 | 1.00 |
SS Innovations International has a consensus price target of $7.00, indicating a potential upside of 165.15%. Given SS Innovations International’s higher possible upside, analysts plainly believe SS Innovations International is more favorable than Terumo.
Summary
Terumo beats SS Innovations International on 10 of the 12 factors compared between the two stocks.
About Terumo
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.
About SS Innovations International
AVRA Medical Robotics, Inc. develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc. and changed its name to AVRA Medical Robotics, Inc. in November 2015. AVRA Medical Robotics, Inc. was founded in 2015 and is based in Orlando, Florida.
Receive News & Ratings for Terumo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terumo and related companies with MarketBeat.com's FREE daily email newsletter.
